In triple-negative breast cancer, FUS facilitates the cyclization of circTBC1D14 by binding the downstream flanking sequence of circTBC1D14, which promotes the progression and aggressiveness of triple-negative breast cancer in vivo [166]. The gene discussed is FUS; the disease is triple-negative breast carcinoma.